Allergic asthma
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- A asthma with a basis in a pathological type I hypersensitivity reaction.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Allergic asthma
- Therapeutic area
- Pulmonology
- allergic asthma
- allergic form of asthma
- Severity
- Moderate
- Immunology
- Pulmonology
- MONDO ID
- MONDO:0004784
- Parent condition
- MONDO:0000771
Related records
Broader conditions (11)
- Allergic disease
- Allergic respiratory disease
- Asthma
- Bronchial disorder
- Disease
- Disease by body system or component
- Human disease
- Hypersensitivity reaction disease
- Immune system disorder
- Lower respiratory tract disorder
- Respiratory system disorder
Narrower conditions (1)
- Isocyanate induced asthma
Trials (133)
- 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma
- A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients
- A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy
- A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
- A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)
- A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL
- A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
- A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
- A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy
- A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers
- A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma
- A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies
- A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
- A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma
- A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma
- abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies
- Airway Immune Response to Allergens (Use Lay Language Here)
- Anakinra as a Rescue Treatment for Allergic Inflammation
- Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma
- Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation
Drugs in development (16)
- Albuterol sulfate Phase 1
- ARRY-502 Phase 2
- AZD-8848 Phase 2
- Briquilimab Phase 1
- CNTO-5825 Phase 1
- Dupilumab Phase 2
- Eculizumab Phase 2
- FB-825 Phase 2
- Gamma-tocopherol Phase 2
- Lebrikizumab Phase 2
- Levocetirizine dihydrochloride Phase 3
- Omalizumab Phase 3
- Pemirolast Phase 2
- Roflumilast Phase 2
- Seratrodast Phase 3
- Tezepelumab Phase 2
Other linked drugs (5)
- Fluticasone
- Montelukast
- Montelukast sodium
- Salmeterol
- Triamcinolone acetonide